Next Article in Journal
Raman Mapping-Based Reverse Engineering Facilitates Development of Sustained-Release Nifedipine Tablet
Next Article in Special Issue
Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
Previous Article in Journal
Poly (N-Vinylcaprolactam-Grafted-Sodium Alginate) Based Injectable pH/Thermo Responsive In Situ Forming Depot Hydrogels for Prolonged Controlled Anticancer Drug Delivery; In Vitro, In Vivo Characterization and Toxicity Evaluation
Previous Article in Special Issue
High-Dose Acetaminophen Alters the Integrity of the Blood–Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats
 
 
Review

Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid

Laboratory of Pharmaceutical Chemistry, Drug Analysis and Drug Information (FASC), Research Group Experimental Pharmacology (EFAR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium
*
Author to whom correspondence should be addressed.
Academic Editor: Flávia Sousa
Pharmaceutics 2022, 14(5), 1051; https://doi.org/10.3390/pharmaceutics14051051
Received: 7 April 2022 / Revised: 7 May 2022 / Accepted: 11 May 2022 / Published: 13 May 2022
(This article belongs to the Special Issue Brain-Targeted Drug Delivery)
Gaining insights into the pharmacokinetic and pharmacodynamic properties of lead compounds is crucial during drug development processes. When it comes to the treatment of brain diseases, collecting information at the site of action is challenging. There are only a few techniques available that allow for the direct sampling from the cerebral interstitial space. This review concerns the applicability of microdialysis and other approaches, such as cerebral open flow microperfusion and electrochemical biosensors, to monitor macromolecules (neuropeptides, proteins, …) in the brain. Microdialysis and cerebral open flow microperfusion can also be used to locally apply molecules at the same time at the site of sampling. Innovations in the field are discussed, together with the pitfalls. Moreover, the ‘nuts and bolts’ of the techniques and the current research gaps are addressed. The implementation of these techniques could help to improve drug development of brain-targeted drugs. View Full-Text
Keywords: microdialysis; cerebral open flow microperfusion; electrochemical biosensors; macromolecules microdialysis; cerebral open flow microperfusion; electrochemical biosensors; macromolecules
Show Figures

Figure 1

MDPI and ACS Style

Custers, M.-L.; Nestor, L.; De Bundel, D.; Van Eeckhaut, A.; Smolders, I. Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid. Pharmaceutics 2022, 14, 1051. https://doi.org/10.3390/pharmaceutics14051051

AMA Style

Custers M-L, Nestor L, De Bundel D, Van Eeckhaut A, Smolders I. Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid. Pharmaceutics. 2022; 14(5):1051. https://doi.org/10.3390/pharmaceutics14051051

Chicago/Turabian Style

Custers, Marie-Laure, Liam Nestor, Dimitri De Bundel, Ann Van Eeckhaut, and Ilse Smolders. 2022. "Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid" Pharmaceutics 14, no. 5: 1051. https://doi.org/10.3390/pharmaceutics14051051

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop